We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Global Health | LSE:GHP | London | Ordinary Share | GB00B23TTS84 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 115.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:4726S Global Health Partner PLC 16 April 2008 Global Health Partner plc ("GHP" or the "Company") Acquisition the shares in ORADENT AB GHP is pleased to announce that it has, today, completed the acquisition of 100 percent of ORADENT AB, the largest private supplier of highly specialised oral rehabilitation in Sweden. Acquisition details GHP has acquired 100 percent of the shares in Oradent AB for approximately £5.4 million. The acquisition was financed by the issuance of approximately 1,430,000 shares at 122 pence per share and approximately £3.6 million in cash. Oradent AB is a holding company owning 100 percent of Credentus AB that in its turn is the unlimited partner of Specialistkliniken for Dentala Implantat KB ("SFDI KB"), a limited liability partnership. The structure with eight of the working specialists owning limited partner's shares in SFDI KB is in line with the GHP partnership model. In the latest twelve months' financial statements to December 31, 2007 Oradent AB had consolidated revenues of approximately £3.9 million and earnings before tax of approximately £1.2 million on its accounting basis whereof approximately £0.4 million was allocated to the limited partners in SFDI KB, translated at current rates of exchange. Gross assets are approximately £3.1 million. Deferred consideration of between 0 and 5 per cent. of the initial consideration value may become payable in 2009, 2010 and 2011 in cash on the fulfilment, at that time, of certain conditions. The Oradent group SFDI KB is the operating company and conducts its business in fully owned premises outside of Stockholm in Nacka. The unlimited partner, Credentus AB, runs a fully owned dental laboratory within the premises and supplies the clinic with dental appliances. Development of the Dental Service Line within GHP GHP believes that this acquisition is an important step in the building of the dental service line as the clinic is the largest private clinic for specialized oral rehabilitation in Sweden. It will give GHP a definite presence in the Swedish oral rehabilitation market. The clinic is also the only private specialized oral rehabilitation centre in Sweden that is licensed by the National Swedish Board of Health and Welfare to educate and graduate specialists in Prosthetic Dentistry. Commenting on the proposed acquisition, Per Batelson, Chairman and Chief Executive of GHP, said: "I am excited by the acquisition of the Oradent group since it will be a mile stone in growing the GHP Dental Service Line. By adding this centre to our present Dental companies we are a player to be reckoned with in the Swedish market place and have drastically increased both our network and our ability to grow organically." CONTACTS: Per Batelson, GHP CEO: 00-46-3116-7890 or: 00-46-705-955700 James Thornton, GHP Corporate Finance Director and Company Secretary: 0207-665-1833 or: 07788-975-633 Ivonne Cantu / Elizabeth Bowman, Cenkos Securities Plc 0207-397-8900 This information is provided by RNS The company news service from the London Stock Exchange END ACQIFMTTMMBBBBP
1 Year Global Health Chart |
1 Month Global Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions